Related Experiment Videos

Epigenetics and epimutagens: some new perspectives on cancer, germ line effects and endocrine disrupters

D G MacPhee1

  • 1School of Microbiology, La Trobe University, Bundoora, Victoria 3083, Australia. micdgm@lure.latrobe.edu.au

Mutation Research
|August 1, 1998
PubMed

Insights

Chemicals can epigenetically alter cell phenotypes without changing DNA sequence. This review discusses epimutations in human carcinogenesis and inheritance, and endocrine disruptors within chemical hazard assessment.

Area of Science:

  • Epigenetics and Chemical Carcinogenesis
  • Genomic Instability and Heritable Changes

Background:

  • Mammalian cell phenotypes can be altered epigenetically by chemicals like base analogues and reactive oxygen species.
  • Epigenetic modifications, which do not alter DNA sequence, have significant implications but are understudied in mutation research.
  • Confusion in terminology and reluctance to accept heritable non-sequence DNA changes may hinder research.

Purpose of the Study:

  • To review the outcomes of epimutagenic changes in human carcinogenesis and germline inheritance.
  • To contextualize endocrine disruptors within a broader chemical hazard framework for mode of action analysis.

Main Methods:

  • Review of existing literature on epimutations and chemical carcinogenesis.
  • Analysis of spontaneous and induced epimutagenic changes.
  • Discussion of endocrine disruptors' mechanisms of action.

Main Results:

  • Epimutagenic changes can impact human carcinogenesis and germline inheritance.
  • Endocrine disruptors can be analyzed within a broader chemical hazard framework.

Conclusions:

  • Epigenetic alterations represent a significant, yet underexplored, area in mutation research.
  • Understanding epimutations is crucial for assessing chemical hazards, including endocrine disruptors, and their impact on health and inheritance.

Related Concept Videos